ASIA — Asia Green Biotechnology Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Asia Green Biotechnology, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.767 | -0.553 | -0.525 | -0.198 | -0.221 |
| Non-Cash Items | 0.17 | 0 | 0.035 | 0 | 0.052 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.074 | -0.088 | 0.026 | 0.068 | 0.133 |
| Change in Accounts Receivable | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -0.671 | -0.641 | -0.464 | -0.13 | -0.036 |
| Financing Cash Flow Items | -0.053 | 0 | — | — | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.21 | 0 | 0.15 | 0.075 | 0.025 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.538 | -0.641 | -0.314 | -0.055 | -0.011 |